Patient Guide · The Science

What is hyperbolic tapering? The idea that makes coming off safe.

Why the last little dose is the hardest to give up — and the simple idea that fixes it.

If you crashed at the lowest dose, the curve betrayed you — not your willpower. Once you understand the shape of the curve, the whole reason tapers go wrong — and how to do them right — clicks into place.

If you’ve ever wondered why the last little dose was the hardest to give up — harder than the big cuts earlier — this is the answer. It’s called hyperbolic tapering, and once you see it, the whole process makes sense.

Education, not medical advice. This explains the idea behind a safe taper. The actual plan should always be made with your prescriber and matched to you.

The straight-line mistake

Most tapers are done in equal milligram steps — drop 10 mg, then another 10 mg, then another. It seems fair. But the brain doesn’t respond to dose in a straight line, so equal-sized cuts do not create equal-sized effects. The early cuts feel like nothing. The last ones feel enormous.

The curve, in plain English

The relationship between a dose and its effect on brain receptors is a curve, not a line. At higher doses the receptors are nearly “full,” so a big milligram cut barely changes the effect. At low doses, even a tiny cut removes a large share of the remaining effect. That’s why coming down from a small dose to zero can knock people flat — the final stretch is doing the heaviest lifting.

Equal milligram cuts aren’t equal. The curve is why the bottom of the taper is the hardest part.

The fix: shrink by percentage, not by milligrams

Hyperbolic tapering means reducing by a percentage of your current dose — often around 10% — rather than a fixed amount. As the dose gets smaller, so do the steps. Each reduction then feels about the same, the whole way down. The result is a taper that gets gentler exactly where the old way got brutal.

What that looks like in practice

  • Reductions sized to your current dose, not a fixed pill fraction
  • Holding each step a few weeks until you feel steady
  • The smallest steps saved for the very end
  • Often needing liquid medication or compounded micro-doses to make low doses possible

This approach is at the heart of The Maudsley Deprescribing Guidelines, and it applies to antidepressants (SSRIs and SNRIs) and, with extra care, to benzodiazepines too.

You don’t have to figure this out alone.

The people who come off most comfortably almost always have a Provider doing it with them — someone who knows the slow way.

Find a Provider near you →

Why it matters

When people “fail” at coming off a medication, the method usually failed them — not the other way around. Hyperbolic tapering is the difference between a cliff and a gentle ramp. The catch is that it requires doses smaller than standard tablets allow, which is where a Provider who does this comes in.

Questions people often ask

What does “hyperbolic” actually mean here?

It refers to the curved (not straight-line) relationship between a medication’s dose and its effect on the brain. Because of that curve, reductions should shrink by percentage, not by fixed milligram amounts.

Why is the last, lowest dose the hardest?

At low doses, a small milligram cut removes a large share of the remaining effect. That’s why dropping from a low dose to zero can feel harder than the bigger cuts earlier on.

Does hyperbolic tapering work for benzodiazepines too?

The same percentage-based principle applies to benzodiazepines, but they require extra caution and supervision because abrupt stops can cause seizures.

Why do I need liquid or compounded medication?

Standard tablets don’t go low enough for the small final steps. Liquids and compounded micro-doses let you reduce by small percentages all the way to zero.

You shouldn’t have to do this by yourself

Find a Provider who knows the slow way.

Most prescribers learned to stop these medications in a few weeks. Coming off safely usually takes months — and a method many were never taught. Our directory lists Providers trained in slow, hyperbolic tapering. Search your area and take the next step with someone beside you.

Find a Provider →

Go deeper

Longer, fully referenced articles on this topic:

References

  1. Horowitz MA, Taylor D. The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs. Wiley-Blackwell; 2024. PMC review. Link
  2. Brunner E, Chen C-YA, Klein T, et al. The Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Benzodiazepine Risks Outweigh Benefits. American Society of Addiction Medicine and American College of Medical Toxicology. 2025. PMC. Link
  3. Sørensen A, Ruhé HG, Munkholm K. The relationship between dose and serotonin transporter occupancy of antidepressants: a systematic review. Mol Psychiatry. 2022;27(1):192-201. PMC. Link
  4. Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019;6(6):538-546. Lancet. Link
  5. Royal College of Psychiatrists. Stopping antidepressants: patient and clinician guidance. RCPsych. Link
  6. Pottie K, Thompson W, Davies S, et al. Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339-351. PMC. Link
  7. Iyer S et al. Outcomes of hyperbolic tapering of antidepressants. 2023. PMC. Link
  8. Robertson S, Peacock EE, Scott R. Benzodiazepine Use Disorder: Common Questions and Answers. American Family Physician. 2023;108(3):260-266. AAFP. Link
  9. Therapeutics Initiative / NCBI Bookshelf. How to stop antidepressants (Therapeutics Letter 157). 2025. NCBI Bookshelf. Link
  10. 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023. PMC. Link

Built from real medical research, not internet rumors The Maudsley Deprescribing Guidelines (Wiley, 2024) · Horowitz & Taylor, hyperbolic tapering (Lancet Psychiatry, 2019)